Vital Signs The Analyst's Perspective - September 2015 Issue

Vital Signs The Analyst's Perspective - September 2015 Issue

RELEASE DATE
30-Sep-2015
REGION
Asia Pacific
Research Code: 9A35-00-40-00-00
SKU: HC02617-AP-MR_16739
$450.00
In stock
SKU
HC02617-AP-MR_16739
$450.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This issue of Vital Signs discusses the acquisition of Cellular Research by Beckton Dickinson, collabaration of Illumina and Asuragen on companion diagnostics, a landmark NIH study on blood pressure management, and drug price hikes.

Table of Contents

Related Research
This research service presents an overview and analysis of the contract research organization (CRO) market. It provides revenue forecasts for the CRO market by phase and therapeutic type. The study discusses the key challenges, unmet needs, and emerging trends in the market and. It covers the complete life cycle of the CRO industry, starting from preclinical trials to post-marketing surveillance. It provides detailed information on support services such as central laboratory services, bioanalytics, and data management.
More Information
No Index No
Podcast No
Author Christi Bird
Industries Healthcare
WIP Number 9A35-00-40-00-00
Is Prebook No